NEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong are investigating the Board of Directors of Inspire Pharmaceuticals, Inc. (Nasdaq: ISPH) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Merck (NYSE: MRK). Under the terms of the deal, Inspire shareholders will receive $5.00 in cash per share of Inspire stock. The transaction has a total value of approximately $430 million.
The investigation concerns whether the Inspire Board of Directors breached their fiduciary duties to Inspire stockholders by failing to adequately shop the Company before entering into this transaction and whether Merck is underpaying for Inspire shares. According to Thomson/First Call, at least one analyst set a price target of $10.00 for Inspire shares.
If you own common stock in Inspire and wish to obtain additional information, please contact Vincent Wong, Esq. either via email email@example.com, by telephone at 212.584.2740, or visit http://www.wongesq.com/inspire-pharmaceuticals.html.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.